the michael farr, the man of contradiction. this what's your fake a lot of surgeries were put off during the pandemic? do you believe they continue to show strength in future quarters. >> i do. i love the numbers this morning, teebl on the top line, bottom line, and increased guidance one of my top ten stocks for the year it's not been a fabulous performer year to date, up 13% so it's lagged the market so far. i think that this is a good steady company and there are four things i like going forward. they've been investing in their pipeline for years new products, new developments, they spent money there those profits are coming on line here e.r. enal cath et wers medical devices. sailing at a selling a 5% discount to the peer group and a fabulous balance sheet this is a name looks like a core holding for me i hope for quite a while. >> steph, turning it over to you, you recently added to one of your health care positions, adding johnson & johnson stock what was the motivation there? >> it has lag the market as well, up 12% trad

i'm seeing some call activity today. >> michael farr?ing back, it's a higher margin business 12 times earnings, a 15% grower. so a discount to its growth rate plus a dividend, i love it. >> stephanie link. >> nxpi. they beat, they raised earnings grew 43%. total revenue guide of 10% versus 7% and the stock opened down so silly season continues. i'd be a buyer. >> last but not least, the reform broker, josh brown, with the final trade. >> bristol myers breakout in progress coming out of the five-year consolidation period the bigger the base, the bigger the space. i like it here. >> good stuff. thanks, everybody. "the exchange" is now. >>> thanks, scott. hi, everybody. i'm eamon javers at cnbc headquarters filling in for kelly evans today. here's what's ahead. another trillion dollars being pumped into the economy, this time in that bipartisan infrastructure bill. what's all this spending doing to the national debt we'll ask the head of the national economic council. he'lljoin us live from the white house north lawn in just a couple of min

joining us now, michael farr from farr miller and lins lin pp piegza. >> we're seeing early signs of that looking at this morning's report, the headline increase was starting, as expected. it will likely remain at mult multi-decade highs through the end of the year. if we look at the underlying momentum, particularly in the core, up .3%, this is the weakest or slowest monthly increase we've seen since the first quarter. it does suggest at least we're seeing early indications of that second derivative decline, slower pace of positive increase something we've seen broad based for several months now is the fact that a lot of these price pressures are really concentrated in some of these areas that have been hard hit by the virus and subsequent policy. as the economy recalibrates, as we work through these supply chain disruptions, this is where the fed says we will start to see those price pressures abate. as you pointed out we are starting to see that, at least in some categories. >> michael farr, it might be an easier call. for the stock market, either way they have some support but fo

stephanie link, michael farr jon najarian co-founder of market rebellion.com and kate moorehead of thebal allocation team. let's check the markets. nasdaq hitting an all-time high reaching 15,000 for the first time ever. th